Virax has one of the most advanced clinical programs on ASX, with 5 mid-stage clinical trials running under two separate INDs over next 12 months
Just compare us with IMU , they will have 1.3 to 1.4B shares post spp with maybe 4-5m cash post current spp , they have a value of 16-18m post spp at current price of 1.2c and will start their only phase 1b trial in mid 2015 .
VHL , market value just above 8m and cash just above $3m
Based on IMU alone we should be valued above 2c imo , i think we may have seen the last of the sellers , those who bought between 0.5 and 0.6 between may and october.
Virax has one of the most advanced clinical programs on ASX,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.002(7.69%) |
Mkt cap ! $48.11M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.7¢ | $44.61K | 1.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 579398 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 2318208 | 1 |
View Market Depth
| Last trade - 15.52pm 29/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |